Report : Middle East & Africa GMP Testing Service Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Service Type (Product Validation Testing, Bioanalytical Services, Packaging & Shelf Life Testing, and Other Services Type) and End User (Pharmaceutical and Biopharmaceutical Companies, and Medical Device Companies)
At 5.8% CAGR, the Middle East & Africa GMP Testing Service Market is speculated to be worth US$ 58.64 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the Middle East & Africa GMP testing service market was valued at US$ 41.84 million in 2022 and is expected to reach US$ 58.64 million by 2028, registering a CAGR of 5.8% from 2022 to 2028. Continuous production of pharmaceuticals industry and flourishment of medical device business are the critical factors attributed to the Middle East & Africa GMP testing service market expansion.
Many life sciences companies are falling behind maturity in terms of the adoption of robotics and cognitive automation (R&CA). The USFDA Regulation 21 requirements have led to uncertainties about R&CA, and their potential impact on human safety has decelerated the progress of the GMP testing industry. Despite the lag in technological adoption, the use of automation is gradually becoming commonplace across pharmaceutical, medical device, and biotechnology companies, especially in various stages of clinical trials and regulatory compliance. The Industry 4.0, enabling connectivity, advanced analytics, robotics, and automation, can revolutionize every aspect of pharma manufacturing laboratories in the next 5–10 years. Its first use cases have been demonstrated to deliver a 30–40% surge in productivity in mature and efficient lab environments; moreover, further improvements could lead to more than 50% reductions in the overall quality-control costs. Digitization and automation ensure better quality and compliance by reducing manual errors and variability, simultaneously enabling the faster and more effective resolution of problems. Robotic process automation and cognitive automation, and validation are likely to contribute to the following processes, as a part of GMPs: Streamlining the tedious product labeling process. Supporting advancements in pharmacovigilance by providing the tools and ability to process data on product quality and distribution. Maintaining official records required by predicate rules, subject to inspection under FDA requirements, such as study protocols for new drug applications. Enhancing the effectiveness of training and learning management systems (LMS) by automating training assignments, identifying gaps, and facilitating communications with respective personnel. Identifying high-risk abnormalities in images, such as radiology reports, through large-scale interpretation and processing of the data of clinical trials. This is expected to drive the Middle East & Africa GMP testing service market during the forecast period.
On the contrary, want of uniform regulatory framework related to GMP testing services hurdles the growth of Middle East & Africa GMP testing service market.
Based on service type, the Middle East & Africa GMP testing service market is categorized into product validation testing, bioanalytical services, packaging & shelf-life testing, and other services type. The product validation testing segment held 36.7% of the Middle East & Africa GMP testing service market share in 2022, amassing US$ 15.35 million. It is projected to garner US$ 22.13 million by 2028 to expand at 6.3% CAGR during 2022–2028.
Based on end user, the Middle East & Africa GMP testing service market is bifurcated into pharmaceutical and biopharmaceutical companies and medical device companies. The pharmaceutical and biopharmaceutical companies segment held 80.1% of the Middle East & Africa GMP testing service market share in 2022, amassing US$ 33.53 million. It is projected to garner US$ 47.48 million by 2028 to expand at 6.0% CAGR during 2022–2028.
Based on country, the Middle East & Africa GMP testing service market has been categorized into the Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa. Our regional analysis states that Rest of Middle East & Africa captured 41.8% of the Middle East & Africa GMP testing service market share in 2022. It was assessed at US$ 17.51 million in 2022 and is likely to hit US$ 23.79 million by 2028, exhibiting a CAGR of 5.2% during the forecast period.
Key players dominating the Middle East & Africa GMP testing service market are Eurofins Scientific; Almac Group; INTERTEK GROUP PLC; WuXi AppTec; Sartorius AG; Nelson Laboratories, LLC.; and Thermo Fisher Scientific Inc. (PPD Inc.) among others.
- In April 2022, Expansion of the analysis portfolio in the area of herbal raw materials, herbal extracts and foodstuffs.
- In Feb 2022, Almac Clinical Services’ Just in Time Manufacturing Operations Pass EU Regulatory Inspection.
Contact Person: Sameer Joshi
Email Id: email@example.com